Mesalazine produced improvements of similar magnitude on selected endpoints.<h4>Conclusion</h4>MeV alleviates experimental colitis, at least in part by activating Nrf2/HO-1 to restrain ferroptosis and preserve epithelial barrier integrity. The gene discussed is HMOX1; the disease is colitis.